Dr Braun's primary responsibilities include direct leadership and execution of complex surgeries, including gastric bypass, sleeve gastrectomy, and other advanced metabolic and bariatric procedures. He has developed solid experience in managing the different clinical challenges present in obese patients, providing them with personalized and optimized care to ensure positive long-term outcomes.
His surgical practice is based on an in-depth methodology and a careful look at the latest technological innovations in the field of bariatric surgery. He has actively worked to implement advanced protocols and continually improve operational techniques, while maintaining the highest standards of patient safety and care.
With over 2000 operations performed as a surgeon specializing in oncology, he has developed extensive experience and expertise in laparoscopic and robotic surgery applied to the care of cancer patients.
As a primary operator, he has successfully conducted a wide range of laparoscopic and robotic surgeries for the treatment of oncological conditions, including gastrointestinal, urological, gynecological and other solid tumors. His surgical practice has focused on the application of advanced techniques, using cutting-edge laparoscopic instruments and robotic systems
Mostrar másDr Braun's primary responsibilities include direct leadership and execution of complex surgeries, including gastric bypass, sleeve gastrectomy, and other advanced metabolic and bariatric procedures. He has developed solid experience in managing the different clinical challenges present in obese patients, providing them with personalized and optimized care to ensure positive long-term outcomes.
His surgical practice is based on an in-depth methodology and a careful look at the latest technological innovations in the field of bariatric surgery. He has actively worked to implement advanced protocols and continually improve operational techniques, while maintaining the highest standards of patient safety and care.
With over 2000 operations performed as a surgeon specializing in oncology, he has developed extensive experience and expertise in laparoscopic and robotic surgery applied to the care of cancer patients.
As a primary operator, he has successfully conducted a wide range of laparoscopic and robotic surgeries for the treatment of oncological conditions, including gastrointestinal, urological, gynecological and other solid tumors. His surgical practice has focused on the application of advanced techniques, using cutting-edge laparoscopic instruments and robotic systems
El profesor Riccardo Rosati es el Jefe del Departamento de Cirugía Gastrointestinal (GI) en el Hospital de Investigación San Raffaele en Milán, Italia. Es un cirujano altamente experimentado con más de 30 años de experiencia, con títulos médicos completos en medicina general y cirugía general, así como especialización en cirugía torácica. Es miembro de múltiples asociaciones quirúrgicas y ha escrito más de 300 publicaciones. Su departamento trata aproximadamente 2,000 casos quirúrgicos por año.
Mostrar másEl profesor Riccardo Rosati es el Jefe del Departamento de Cirugía Gastrointestinal (GI) en el Hospital de Investigación San Raffaele en Milán, Italia. Es un cirujano altamente experimentado con más de 30 años de experiencia, con títulos médicos completos en medicina general y cirugía general, así como especialización en cirugía torácica. Es miembro de múltiples asociaciones quirúrgicas y ha escrito más de 300 publicaciones. Su departamento trata aproximadamente 2,000 casos quirúrgicos por año.
Prof. Deraco has dedicated his career to helping patients with complex cancers, particularly those affecting the peritoneum, a membrane in the abdomen. He began his medical career in 1989 at the Surgery and Experimental Oncology Departments of the Fondazione IRCCS, National Cancer Institute in Milan, Italy. Over the years, he has played a key role in advancing treatments for peritoneal surface malignancies (PSM). For more than a decade, he was the lead physician for the Peritoneal Surface Malignancies Program. Since 2017, he has served as the director of the Peritoneal Surface Malignancies Unit, where he continues to focus on providing cutting-edge care for his patients.
Prof. Deraco’s expertise is in specialized cancer treatments like Cytoreductive Surgery (CRS), Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC), and Pressurized Intra-Peritoneal Aerosolized Chemotherapy (PIPAC). These techniques aim to remove cancer and deliver heated chemotherapy directly to the abdomen, giving patients with PSM new hope. He has successfully treated over 1,200 patients using these advanced methods.
In addition to his clinical work, Prof. Deraco is a professor at Milan University, where he teaches future surgeons about peritoneal surface malignancies. His teaching extends internationally, as he has mentored over 30 postdoctoral fellows from prestigious institutions worldwide.
Prof. Deraco’s educational background is extensive. He earned his medical degree from the University of Messina in 1987 with top honors, followed by a specialization in general surgery five years later. His training continued in Paris, where he specialized in oncology at the prestigious Paris Dauphine University. He further honed his skills through fellowships in world-renowned institutions such as the Gustave Roussy Institute in France, the Royal Marsden Hospital in the UK, and the Washington Cancer Institute in the USA.
Throughout his career, Prof. Deraco has remained actively involved in research and professional organizations. He has published over 250 scientific articles and 25 book chapters, contributing to the advancement of cancer treatment globally. He serves on the board of multiple scientific societies dedicated to cancer research, including the Peritoneal Surface Oncology International Group (PSOGI) and the Italian Society for Loco-Regional Cancer Therapy (SITILO).
Mostrar másProf. Deraco has dedicated his career to helping patients with complex cancers, particularly those affecting the peritoneum, a membrane in the abdomen. He began his medical career in 1989 at the Surgery and Experimental Oncology Departments of the Fondazione IRCCS, National Cancer Institute in Milan, Italy. Over the years, he has played a key role in advancing treatments for peritoneal surface malignancies (PSM). For more than a decade, he was the lead physician for the Peritoneal Surface Malignancies Program. Since 2017, he has served as the director of the Peritoneal Surface Malignancies Unit, where he continues to focus on providing cutting-edge care for his patients.
Prof. Deraco’s expertise is in specialized cancer treatments like Cytoreductive Surgery (CRS), Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC), and Pressurized Intra-Peritoneal Aerosolized Chemotherapy (PIPAC). These techniques aim to remove cancer and deliver heated chemotherapy directly to the abdomen, giving patients with PSM new hope. He has successfully treated over 1,200 patients using these advanced methods.
In addition to his clinical work, Prof. Deraco is a professor at Milan University, where he teaches future surgeons about peritoneal surface malignancies. His teaching extends internationally, as he has mentored over 30 postdoctoral fellows from prestigious institutions worldwide.
Prof. Deraco’s educational background is extensive. He earned his medical degree from the University of Messina in 1987 with top honors, followed by a specialization in general surgery five years later. His training continued in Paris, where he specialized in oncology at the prestigious Paris Dauphine University. He further honed his skills through fellowships in world-renowned institutions such as the Gustave Roussy Institute in France, the Royal Marsden Hospital in the UK, and the Washington Cancer Institute in the USA.
Throughout his career, Prof. Deraco has remained actively involved in research and professional organizations. He has published over 250 scientific articles and 25 book chapters, contributing to the advancement of cancer treatment globally. He serves on the board of multiple scientific societies dedicated to cancer research, including the Peritoneal Surface Oncology International Group (PSOGI) and the Italian Society for Loco-Regional Cancer Therapy (SITILO).
Prof. Filippini began his career in 1980 and has been teaching at the University of Chieti since the 1990s in the fields of General Surgery, Microsurgery, Reconstructive Surgery, Vascular Surgery, Orthopedics, and Gynecology. His primary focus is oncological surgery, particularly specializing in "The surgical treatment of locally advanced tumors and multi-organ resections." He has enriched his expertise by visiting prominent reference centers in the United States, including the Memorial Sloan Kettering Cancer Center in Manhattan, New York City. There, he delved into minimally invasive, laparoscopic, and microsurgical techniques under the guidance of esteemed mentors such as John Daly, Michele Gagner, and Murray Brennan. Additionally, in 2005, he further expanded his skills at the City of Hope Oncology Center in Los Angeles, focusing on robotic surgery in oncology.
In 1980, Prof. Filippini graduated in Medicine and Surgery from the G. D'Annunzio University of Chieti in Italy with honors, presenting an experimental thesis on lympho-venous anastomosis using microsurgical techniques. He completed his specialization in general surgery at the University of Pisa with distinction after five years. In 1990, he obtained another specialization in Plastic and Reconstructive Surgery from the University of Padua in Italy, where he maintained a stellar academic record.
Prof. Filippini has presented at numerous national and international conferences and authored over 100 scientific publications. Additionally, he has co-authored two monographs.
Mostrar másProf. Filippini began his career in 1980 and has been teaching at the University of Chieti since the 1990s in the fields of General Surgery, Microsurgery, Reconstructive Surgery, Vascular Surgery, Orthopedics, and Gynecology. His primary focus is oncological surgery, particularly specializing in "The surgical treatment of locally advanced tumors and multi-organ resections." He has enriched his expertise by visiting prominent reference centers in the United States, including the Memorial Sloan Kettering Cancer Center in Manhattan, New York City. There, he delved into minimally invasive, laparoscopic, and microsurgical techniques under the guidance of esteemed mentors such as John Daly, Michele Gagner, and Murray Brennan. Additionally, in 2005, he further expanded his skills at the City of Hope Oncology Center in Los Angeles, focusing on robotic surgery in oncology.
In 1980, Prof. Filippini graduated in Medicine and Surgery from the G. D'Annunzio University of Chieti in Italy with honors, presenting an experimental thesis on lympho-venous anastomosis using microsurgical techniques. He completed his specialization in general surgery at the University of Pisa with distinction after five years. In 1990, he obtained another specialization in Plastic and Reconstructive Surgery from the University of Padua in Italy, where he maintained a stellar academic record.
Prof. Filippini has presented at numerous national and international conferences and authored over 100 scientific publications. Additionally, he has co-authored two monographs.
El profesor Michele Reni es un oncólogo médico experimentado con más de 30 años de práctica con sede en Italia. Se especializa en adenocarcinoma de páncreas, cánceres gastroesofágicos y tumores del sistema nervioso central. Ha publicado más de 180 artículos sobre el tratamiento del cáncer y es el coordinador de las directrices de la Asociación Italiana de Oncología Médica (AIOM) para el tratamiento y manejo del cáncer de páncreas. También ha presidido numerosos ensayos clínicos sobre el tratamiento de pacientes con cáncer de páncreas metastásico.
Mostrar másEl profesor Michele Reni es un oncólogo médico experimentado con más de 30 años de práctica con sede en Italia. Se especializa en adenocarcinoma de páncreas, cánceres gastroesofágicos y tumores del sistema nervioso central. Ha publicado más de 180 artículos sobre el tratamiento del cáncer y es el coordinador de las directrices de la Asociación Italiana de Oncología Médica (AIOM) para el tratamiento y manejo del cáncer de páncreas. También ha presidido numerosos ensayos clínicos sobre el tratamiento de pacientes con cáncer de páncreas metastásico.